GSK2018682
GSK2018682 is an agonist for S1P1 and S1P5 receptor with pEC50s of 7.7 and 7.2, respectively, and has no agonist activity towards human S1P2, S1P3, or S1P4. GSK2018682 is used in the research of multiple sclerosis.
Product Specifications
CAS Number
[1034688-30-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/GSK2018682.html
Concentration
10mM
Purity
99.39
Solubility
DMSO : ≥ 125 mg/mL
Smiles
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
Molecular Formula
C22H21ClN4O4
Molecular Weight
440.88
Precautions
H302, H315, H319, H335
References & Citations
[1]Xu J, et al. Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. Clin Pharmacol Drug Dev. 2014 May;3 (3) :170-8.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1054187-01 0.02 mg (E-Coli)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details 
MBS1054187-02 0.1 mg (E-Coli)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details 
MBS1054187-03 0.02 mg (Yeast)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details MBS1054187-04 0.1 mg (Yeast)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details MBS1054187-05 0.02 mg (Baculovirus)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details MBS1054187-06 0.02 mg (Mammalian-Cell)
Recombinant Thioalkalivibrio sp. UPF0178 protein Tgr7_2584 (Tgr7_2584)
Ask
View Details